Ketamine for the Treatment of Depression (2 commentaries)

OPEN Foundation
September 1, 2017

Link to full text (1)
Link to full text (2)

OPEN Foundation

Share This Post

get the latest

The OPEN Minded Newsletter keeps you informed about the latest psychedelic research & news, articles, exclusive events, job opportunities, programmes, and free resources!

By clicking SUBSCRIBE, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.

Recent articles & news

The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders

Ketamine-Assisted Psychotherapy for Mental Disorders: What Does the Evidence Actually Show?

The Perils of Non-Hallucinogenic Claims: On the Limits of Translatability

DMT and the Brain: A New Doorway Into Brain Renewal

The Promise of Non-Hallucinogenic Psychedelics: A Field Coming Into Focus

Psilocybin and Aging: Early Evidence from Human Cells and Mice

DMT Enhances Brain Recovery After Stroke: A New Frontier for “The Spirit Molecule”

First Patient Included Marks Major Milestone in EU-Funded Clinical Trial

Germany’s Landmark Compassionate Use Program for Psilocybin: A New Wave for Psychedelic Medicine in Europe

Ketamine for the Treatment of Depression (2 commentaries)

OPEN Foundation

Share This Post

get the latest

Recent articles & news

OPEN

ABOUT

EVENTS

RESOURCES

PROGRAMMES

ACTIONS

Ketamine for the Treatment of Depression (2 commentaries)

OPEN Foundation

Share This Post

get the latest

Recent articles & news

OPEN

ABOUT

EVENTS

RESOURCES

PROGRAMMES

ACTIONS

Join an upcoming event

Be at the forefront of psychedelic research and therapy